| Name | Valley Drug |
|---|---|
| Organization Name | Valley Drug Of Malta, Inc. |
| Location | 131 S 1st Ave East, Malta, Montana 59538 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (406) 654-2038 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A University of Texas at Arlington professor led a federal advisory group that has published its recommendations on the prevention of acute and chronic pain to the Federal Research Pain Strategy, an interagency committee that oversees the government's long-term strategic plan to support pain research.
TLC Vision Corporation, North America's premier eye care services company, said today that it has reached an agreement with holders of a majority of the Company's senior secured debt to restructure its balance sheet.
From Jennifer Lahl and The Center for Bioethics and Culture, producers of the award-winning Eggsploitation (2010), Anonymous Father's Day presents the untold stories of children of sperm donors.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 2 clinical trial in Canada with its novel defensin-mimetic antibiotic, PMX-30063.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olanzapine Tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg.
› Verified 2 days ago
| NPI Number | 1972687937 |
| Organization Name | VALLEY DRUG OF MALTA, INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 131 S 1st Ave E, Malta, MT 59538 |
| Phone Number | 406-654-2632 |
News Archive
A University of Texas at Arlington professor led a federal advisory group that has published its recommendations on the prevention of acute and chronic pain to the Federal Research Pain Strategy, an interagency committee that oversees the government's long-term strategic plan to support pain research.
TLC Vision Corporation, North America's premier eye care services company, said today that it has reached an agreement with holders of a majority of the Company's senior secured debt to restructure its balance sheet.
From Jennifer Lahl and The Center for Bioethics and Culture, producers of the award-winning Eggsploitation (2010), Anonymous Father's Day presents the untold stories of children of sperm donors.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 2 clinical trial in Canada with its novel defensin-mimetic antibiotic, PMX-30063.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olanzapine Tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg.
› Verified 2 days ago
News Archive
A University of Texas at Arlington professor led a federal advisory group that has published its recommendations on the prevention of acute and chronic pain to the Federal Research Pain Strategy, an interagency committee that oversees the government's long-term strategic plan to support pain research.
TLC Vision Corporation, North America's premier eye care services company, said today that it has reached an agreement with holders of a majority of the Company's senior secured debt to restructure its balance sheet.
From Jennifer Lahl and The Center for Bioethics and Culture, producers of the award-winning Eggsploitation (2010), Anonymous Father's Day presents the untold stories of children of sperm donors.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 2 clinical trial in Canada with its novel defensin-mimetic antibiotic, PMX-30063.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Olanzapine Tablets USP, 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, and 20 mg.
› Verified 2 days ago
Valley Drug Type: Durable Medical Equipment & Medical Supplies Supplier Location: 131 S 1st Ave East, Malta, Montana 59538 Phone: (406) 654-2038 | |
Phillips County Hospital Type: Durable Medical Equipment & Medical Supplies Supplier Location: 311 8th Ave E, Malta, Montana 59538 Phone: (406) 654-1100 |